RUMORED BUZZ ON HEMGENIX

Number of eligible individuals: CDEC mentioned the uncertainty in the amount of individuals with moderately severe to severe hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific gurus consulted by CADTH indicated that some clients that are categorized as getting mild or average ailment could have a extreme bleeding phenotype, w